Company Endocrown S.r.l. with Fiscal Code 38032786
recorded a turnover of 2024 of
103.847,
with a net profit of
-6.642
and having an average number of employees of
3.
The company operates in the field of Activităţi de asistenţă stomatologică having the NACE code 8623.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Endocrown S.r.l.
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
-
-
5.832
13.499
42.567
44.906
58.825
62.031
80.188
103.847
Total Income - EUR
-
-
5.832
13.499
42.567
44.906
58.825
62.031
80.188
103.847
Total Expenses - EUR
-
-
3.633
11.216
15.434
19.271
25.127
26.566
41.990
107.373
Gross Profit/Loss - EUR
-
-
2.199
2.283
27.133
25.634
33.698
35.465
38.198
-3.526
Net Profit/Loss - EUR
-
-
2.141
2.107
26.708
25.185
33.110
34.844
37.412
-6.642
Employees
-
-
2
2
2
2
2
2
2
3
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales increased by 30.2%, from 80.188 euro in the year 2023, to 103.847 euro in 2024.
The Net Profit decreased by -37.203 euro, from 37.412 euro in 2023, to 0 in the last year.
Check the financial reports for the company - Endocrown S.r.l.
Financial Rating - ENDOCROWN S.R.L.
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Endocrown S.r.l.
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Endocrown S.r.l.
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Endocrown S.r.l.
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
11.229 euro in 2024 which includes Inventories of
0 euro, Receivables of
6.334 euro and cash availability of
4.896 euro.
The company's Equity was valued at
-6.593 euro, while total Liabilities amounted to
54.745 euro.
Equity decreased by -43.845 euro, from 37.460 euro in 2023, to -6.593 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Endocrown S.r.l.